BSX Boston Scientific Corporation
Healthcare
Price
$51.00
Intrinsic value
$24.84
Buy price
$19.87
Discount
-105.3%
DCF walkthrough
Near-term growth (g1)16.54%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $4,341,000,000.00
- Total debt
- $12,624,000,000.00
- Cash & STI
- $539,000,000.00
- Shares out.
- 1,474,800,000
Overvalued
Intrinsic value$24.84
Buy price (with MOS)$19.87
Current price$51.00
Discount to intrinsic value-105.3%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 8.2%
- Current ROE
- 12.0%
- Minimum ROE
- 4.0%
Debt quality
MODERATE- Debt / Equity
- 0.52x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.18x
Technical chart
Confluence: DOWNTREND (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 25.7%
- Public economic interest
- 99.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.